EUR 741.00 For Business Accounts Only

Digestive Remedies in Belgium

The worst seems to be over for digestive remedies. The category previously paid for the reverse switch of the gastroprokinetic Motilium brand from Janssen-Cilag (included in antacids) and its consequences over 2014-2015. The scandal surrounding its active ingredient, domperidone, also had detrimental effects on Sanofi’s Primperan and Janssen-Cilag’s Touristil. The drop in sales of traditional antacids such as Maalox and Rennie, the waning profitability of Gaviscon and the decline of fibre and co...

Euromonitor International's Digestive Remedies in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.